-+ 0.00%
-+ 0.00%
-+ 0.00%

Cognition Therapeutics CMO Anthony Caggiano acquires $11,100 common shares

PUBT·04/20/2026 20:16:30
Listen to the news
Cognition Therapeutics CMO Anthony Caggiano acquires $11,100 common shares
  • Cognition Therapeutics Chief Medical Officer Anthony Caggiano reported purchase of 10,000 common shares at USD 1.11 per share.
  • Directly held stake increased to 874,906 common shares following transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cognition Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-045499), on April 20, 2026, and is solely responsible for the information contained therein.